Moleculin Biotech Inc

NASDAQ:MBRX   3:59:41 PM EDT
3.39
+0.04 (+1.19%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Moleculin Biotech Inc Stock, NASDAQ:MBRX

5300 Memorial Drive, Suite 950, Houston, Texas 77007
United States of America
Phone: +1.713.300.5160
Number of Employees: 15

Description

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which engages in the development of treatments for highly resistant cancers and viruses. Its clinical stage drugs include Annamycin, an Anthracycline being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML); and WP1066, an Immune/Transcription Modulator targeting brain tumors, pancreatic cancer, and AML. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.